Literature DB >> 12431679

Evaluation of the new EMIT enzyme immunoassay for the determination of whole-blood tacrolimus concentrations in kidney, heart, and liver transplant recipients.

C J Hesse1, C C Baan, A H M M Balk, H J Metselaar, W Weimar, T van Gelder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12431679     DOI： 10.1016/s0041-1345(02)03510-8

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  2 in total

1.  External evaluation of published population pharmacokinetic models of tacrolimus in adult renal transplant recipients.

Authors:  Chen-Yan Zhao; Zheng Jiao; Jun-Jun Mao; Xiao-Yan Qiu
Journal:  Br J Clin Pharmacol       Date:  2016-02-26       Impact factor: 4.335

2.  Tacrolimus dose requirement in renal transplant recipients is significantly higher when used in combination with corticosteroids.

Authors:  Dennis A Hesselink; Hien Ngyuen; Marike Wabbijn; Peter J H Smak Gregoor; Ewout W Steyerberg; Iza C van Riemsdijk; Willem Weimar; Teun van Gelder
Journal:  Br J Clin Pharmacol       Date:  2003-09       Impact factor: 4.335
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.